Genome Co. is a microbiome research and development company that focuses on the discovery and commercialization of novel probiotics and biologics to enhance human health. Their proprietary GNOCLE™ platform enables the identification of microbial strains that can address specific health conditions, thereby improving treatment options in the field of microbiome medicine.
Funding
Funding not disclosed
Founders
Product
Problem
The development of microbiome-based therapeutics is hindered by the difficulty of identifying and isolating microbial strains with specific functionalities and therapeutic potential. Traditional methods for strain discovery are often inefficient and lack the precision needed to target specific health conditions.
Solution
Genome & Company is a biotechnology company focused on developing novel probiotics and biologics for microbiome-based therapeutics. The company utilizes its proprietary GNOCLE™ platform to identify and characterize microbial strains with the potential to address specific health conditions. This platform enables the discovery of new drug candidates and the development of targeted therapies in areas such as immuno-oncology and inflammatory diseases. Genome & Company is advancing a pipeline of microbiome-based assets, including engineered microbial strains and new biologics, to improve treatment options and patient outcomes.
Target Audience
The primary target audience includes pharmaceutical companies, biotechnology firms, and clinical researchers focused on developing and commercializing microbiome-based therapeutics and diagnostics.
Features
- GNOCLE™ platform for high-throughput screening and identification of microbial strains with therapeutic potential
- Focus on developing novel probiotics and biologics for microbiome-based therapeutics
- Pipeline of drug candidates targeting immuno-oncology and inflammatory diseases
- Development of engineered microbial strains with enhanced functionalities
- Expertise in microbiome research and development, including strain isolation, characterization, and formulation